Clinical Trial Update: Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating activity of trabectedin versus gemcitabine plus docetaxel in uterine leiomyosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Leiomyosarcoma

Drugs mentioned

• Gemzar (gemcitabine)
• Taxotere (docetaxel)
• Yondelis (trabectedin)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Leiomyosarcoma | Phase 2 | Status: COMPLETED